Inventor · disambiguated record
Maria Rosario Romero-Martin
Also filed as: ROMERO-MARTIN MARIA-ROSARIO
7 granted patents·5 pending applications·185 citations·filing 2001–2011
88Inventor score
Top patents by PatentIndex Score
12 records- 0193US6888027B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted May 3, 2005·65 cites·63 claims
- 0291US6960685B2Carbamic acid compounds comprising an ether linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Nov 1, 2005·66 cites·69 claims
- 0388US7183298B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Feb 27, 2007·27 cites·124 claims
- 0483US7981895B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2008·Granted Jul 19, 2011·6 cites·64 claims
- 0582US7880020B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2009·Granted Feb 1, 2011·5 cites·49 claims
- 0679US7569724B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Aug 4, 2009·12 cites·93 claims
- 0770US7629343B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2003·Granted Dec 8, 2009·4 cites·86 claims
- 0856US2005107445A1Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsPROLIFIX LTD·Filed 2004·Application pending·0 cites
- 0954US2008113993A1Barbituric acid analogs as therapeutic agentsVIA ARIOSTO 23·Filed 2008·Application pending·0 cites
- 1050US2011275810A1Carbamic acid compounds comprising a piperazine linkage as hdac inhibitorsWATKINS CLARE J·Filed 2011·Application pending·0 cites
- 1147US2011105572A1Carbamic acid compounds comprising an amide linkage as hdac inhibitorsWATKINS CLARE J·Filed 2011·Application pending·0 cites
- 1238US2003229108A1Barbituric acid analogs as therapeutic agentsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →